Promacta
List of products in the National Drug Code with proprietary name promacta. This medication is used to treat low platelet levels in people who have a certain blood disorder called chronic immune (idiopathic) thrombocytopenia purpura (ITP) or who have chronic hepatitis C. It may also be used to treat people with a certain blood disorder (aplastic anemia). Platelets are a type of blood cell needed to form blood clots and prevent bleeding. Eltrombopag decreases your risk of bleeding by increasing the number of platelets. Eltrombopag acts like a certain natural substance (thrombopoietin) that causes the body to produce platelets.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
0078-0684 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0685 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0686 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0687 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0697 | Promacta | Eltrombopag Olamine | Powder, For Suspension | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0972 | Promacta | Eltrombopag Olamine | Powder, For Suspension | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |